NYSE: CONConcentra Group Holdings Parent Inc Stock
$20.82-0.48 (-2.25%)
Updated Mar 21, 2025
CON Price
$20.82
Fair Value Price
N/A
Market Cap
$2.67B
52 Week Low
$18.89
52 Week High
$24.81
P/E
14.26x
P/B
9.68x
P/S
1.33x
PEG
4.64x
Dividend Yield
0.3%
Revenue
$1.90B
Earnings
$166.54M
Gross Margin
27.8%
Operating Margin
15.56%
Profit Margin
8.8%
Debt to Equity
8.06
Operating Cash Flow
$275M
Beta
0.71
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CON's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
B
CON
Ranked#16 of 43
Ranked#16 of 43
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.21 | A | |
| $13.14 | A | |
| $174.14 | A |
Be the first to know about important CON news, forecast changes, insider trades & much more!
CON News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CON scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CON ($20.82) is trading above its intrinsic value of $9.71, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CON is good value based on its earnings relative to its share price (14.26x), compared to the US market average (31.55x)
P/E vs Market Valuation
CON is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CON due diligence checks available for Premium users.
Valuation
CON price to earnings (PE)
For valuing profitable companies with steady earnings
Company
14.26x
Industry
14.32x
Market
31.55x
CON is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CON is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CON price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
9.68x
Industry
4.29x
CON is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CON price to earnings growth (PEG)
For valuing profitable companies with growth potential
CON is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CON's financial health
Profit margin
Revenue
$465.0M
Net Income
$21.5M
Profit Margin
4.6%
CON's Earnings (EBIT) of $295.73M... subscribe to Premium to read more.
Interest Coverage Financials
CON's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.5B
Liabilities
$2.2B
Debt to equity
8.06
CON's short-term assets ($437.21M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CON's long-term liabilities ($1.92B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CON's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$93.7M
Investing
-$16.7M
Financing
-$30.6M
CON's operating cash flow ($274.68M)... subscribe to Premium to read more.
Debt Coverage Financials
CON vs Medical Care Facility Stocks
Concentra Group Holdings Parent Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.